# Naprelan

NDC: 52427-272
Generic name: Naproxen Sodium
Labeler / Manufacturer: Almatica Pharma LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20140117
Marketing ended: 20270701
FDA application: NDA020353

## Active ingredients

- NAPROXEN SODIUM: 375 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"52427-272"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=52427-272
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e633ff0b-eab7-f167-8d08-e9236e54042b